| Bioactivity | Lafadofensine D-(-)-Mandelic acid is the monoamines reuptake inhibitor. Lafadofensine D-(-)-Mandelic acid has sufficient effects after short-term administration[1]. | ||||||||||||
| Name | Lafadofensine (D-(-)-Mandelic acid) | ||||||||||||
| Formula | C32H32F2N2O6 | ||||||||||||
| Molar Mass | 578.60 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Muneaki Kurimura, et al. N,n-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors. Patent WO2006121218A1. |
Lafadofensine (D-(-)-Mandelic acid)
CAS: F: C32H32F2N2O6 W: 578.60
Lafadofensine D-(-)-Mandelic acid is the monoamines reuptake inhibitor. Lafadofensine D-(-)-Mandelic acid has sufficient
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.